I would like to talk about the qualifications piece and the role of the governing council.
Precisely what you pick up on are the strategic decisions the governing council makes that affect things like whether we are going to do research into over-utilization, certain kinds of uses, and advertising--all the kinds of things causing problems for our health care system that have been driven by pharma interests. Will this person at the table shape CIHR strategies in a way that is problematic, because they are shaped by a conflict of interest? It does go directly to the qualifications issue, I believe.